News Focus
News Focus
icon url

Work Harder

08/17/19 4:42 PM

#14140 RE: Staypositive1 #14139

Mario is following this gal

https://www.researchgate.net/project/TRANSVAC

Check her out, nice reads

Odile Leroy is nominated Managing Director of Institut Pasteur Lille (France) and will leave European Vaccine Initiative on February 28th 2019.

Yet F. Spertini is a co author

https://www.researchgate.net/publication/292629472_Safety_and_immunogenicity_of_novel_candidate_blood-stage_malaria_vaccine_P27A_with_Alhydrogel_R_or_GLA-SE_as_adjuvant_in_healthy_malaria_non-exposed_European_and_malaria_exposed_African_adults_aged_18




icon url

Work Harder

08/17/19 6:07 PM

#14141 RE: Staypositive1 #14139

CYTOS BIOTECHNOLOGY AG , whose main administrative office is at Wagistrasse 25 , CH-8952 Zurich-Schlieren, Switzerland; represented by Dr. Martin Bachmann, Chief Scientific Officer, duly authorised for the purposes hereof; - Hereinafter referred to as “Cytos”

http://filings.irdirect.net/data/927761/000095015208001236/l30222ae8vk.pdf

Medical Research Council

Oxfordshire Centre

Well, whadda ya know
icon url

Work Harder

08/17/19 9:01 PM

#14147 RE: Staypositive1 #14139

It looks to me like

MYMX is totally out on it's own within the TransVac 2 network & that MYMX isn't connected to Big Pharma in any way.

Looks like the world gov's will go w/ the chitty Gsk vaccine that works maybe 50% of the time combination vaccines just like the chitty Hiv treatments all over TV right now

Hopefully we actually get the Malaria results Mr Kempers projected in the second half of this year.

Maybe this fall